haloperidol and valproic acid

haloperidol has been researched along with valproic acid in 117 studies

Research

Studies (117)

TimeframeStudies, this research(%)All Research%
pre-199015 (12.82)18.7374
1990's13 (11.11)18.2507
2000's49 (41.88)29.6817
2010's32 (27.35)24.3611
2020's8 (6.84)2.80

Authors

AuthorsStudies
Andrews, PR; Craik, DJ; Martin, JL1
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Abraham, MH; Acree, WE; Ibrahim, A1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Glen, RC; Lowe, R; Mitchell, JB1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Amata, E; Anfuso, CD; Arena, E; Caporarello, N; Drago, F; Fiorito, J; Giurdanella, G; Lupo, G; Marrazzo, A; Olivieri, M; Prezzavento, O; Rescifina, A; Salerno, L; Vinciguerra, S1
Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E1
Agard, DA; Ashworth, A; Barrio-Hernandez, I; Batra, J; Beltrao, P; Bennett, MJ; Bohn, M; Bouhaddou, M; Braberg, H; Broadhurst, DJ; Cai, Y; Cakir, M; Calviello, L; Cavero, DA; Chang, JCJ; Chorba, JS; Craik, CS; d'Enfert, C; Dai, SA; Eckhardt, M; Emerman, M; Fabius, JM; Fletcher, SJ; Floor, SN; Foussard, H; Frankel, AD; Fraser, JS; Fujimori, DG; Ganesan, SJ; García-Sastre, A; Gordon, DE; Gross, JD; Guo, JZ; Haas, K; Haas, P; Hernandez-Armenta, C; Hiatt, J; Huang, XP; Hubert, M; Hüttenhain, R; Ideker, T; Jacobson, M; Jang, GM; Jura, N; Kaake, RM; Kim, M; Kirby, IT; Klippsten, S; Koh, C; Kortemme, T; Krogan, NJ; Kuzuoglu-Ozturk, D; Li, Q; Liboy-Lugo, J; Lin, Y; Liu, X; Liu, Y; Lou, K; Lyu, J; Mac Kain, A; Malik, HS; Mathy, CJP; McGregor, MJ; Melnyk, JE; Memon, D; Meyer, B; Miorin, L; Modak, M; Moreno, E; Mukherjee, S; Naing, ZZC; Noack, J; O'Meara, MJ; O'Neal, MC; Obernier, K; Ott, M; Peng, S; Perica, T; Pilla, KB; Polacco, BJ; Rakesh, R; Rathore, U; Rezelj, VV; Richards, AL; Roesch, F; Rosenberg, OS; Rosenthal, SB; Roth, BL; Roth, TL; Ruggero, D; Safari, M; Sali, A; Saltzberg, DJ; Savar, NS; Schwartz, O; Sharp, PP; Shen, W; Shengjuler, D; Shi, Y; Shoichet, BK; Shokat, KM; Soucheray, M; Stroud, RM; Subramanian, A; Swaney, DL; Taunton, J; Tran, QD; Trenker, R; Tummino, TA; Tutuncuoglu, B; Ugur, FS; Vallet, T; Venkataramanan, S; Verba, KA; Verdin, E; Vignuzzi, M; von Zastrow, M; Wang, HY; Wankowicz, SA; Wenzell, NA; White, KM; Xu, J; Young, JM; Zhang, Z; Zhou, Y1
Amata, E; Anfuso, CD; Barbaraci, C; Cacciatore, I; Dichiara, M; Giurdanella, G; Leotta, CG; Longo, A; Lupo, G; Marrazzo, A; Pasquinucci, L; Pitari, GM; Prezzavento, O; Turnaturi, R; Zuccarello, E1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Algeri, S; Branciforti, A; Calderini, G; Caraceni, T; Consolazione, A; Dall'olio, A; Girotti, F; Morselli, PL; Riva, E; Spreafico, R1
Avanzini, G; Caraceni, T; Giovannini, P; Girotti, F1
Godwin-Austen, RB1
Barrelet, L; Baumann, P; Touabi, M; Uehlinger, C1
Turner, WJ1
Cennamo, M; Piccione, E; Ticconi, C1
Naranjo, CA; Sellers, EM1
Drake, ME; John, K; Kellum, JB; Pakalnis, A1
Appleton, RE; Jan, JE1
Rogers, J; Troost, BT; Williams, DP1
Newman, G; Shukla, S; Turner, WJ1
Chiba, K; Iizuka, R; Ishizaki, T; Kobayashi, K; Saito, M1
Monninger, P; Przuntek, H1
Bourguignon, A; Cadet, B; Chaneac, D; de Medeiros, P; Monfort, JC1
Lal, S; Nair, NP; Schwartz, G; Thavundayil, JX1
Georgiev, V; Markovska, V1
Kirch, DG; Li, R; Wing, LL; Wyatt, RJ1
Finnerty, M; Levin, Z; Miller, LJ1
Bennett, JA; Keck, PE; McElroy, SL; Stanton, SP; Strakowski, SM; Tugrul, KC1
Barnett, JY; Brasić, JR1
Moore, DP1
Dose, M; Emrich, HM; Hellweg, R; Theison, M; Yassouridis, A1
Berger, M; Brandt, C; Normann, C; Walden, J1
Forleo, LH; Hilario, MO; Len, CA; Ronchezel, MV; Sole, D; Terreri, MT; Vilanova, LC1
Jaggers, ED; Kline, MD1
Berger, M; Hesslinger, B; Klose, P; Langosch, JM; Normann, C; Walden, J1
Giedke, H; Henn, FA; Müller-Oerlinghausen, B; Retzow, A; Walden, J1
Ahmed, W; Ghani, SO; Marco, LA1
Brown, A; Dott, SG; Harris, A; Meyer, WJ; O'Boyle, M; Rose, RM; Wassef, AA1
Hafiz, NG; Hampton, D; Molloy, M; Wassef, AA1
Gundlapalli, SP; Iqbal, MM; Passman, TE; Ryals, T; Ryan, WG1
Hardy-Baylé, MC1
Jagadheesan, K; Nizamie, SH; Ranjan, S1
Bhattacharya, D; Bhattacharya, SK; Ghosal, S; Sairam, K1
Araujo, AP; Maia Filho, HS; Padua, PA1
Bowden, CL; Ghaemi, SN; Grossman, F; Okamoto, A; Sachs, GS1
Cardozo, J; Molina, O; Montiel, C; Mora, E; Peña, J1
Assumpção, FB; Ribeiro, KM; Valente, KD1
Bhattachary, SK; Bhattacharya, D; Muruganandam, AV1
Agam, G; Belmaker, RH; Kozlovsky, N; Nadri, C1
Morita, N; Suetsugu, S1
Coffey, B1
Lopez, LM; Molloy, MS; Wassef, AA; Williams, NG1
Girimaji, SC; Jairam, R; Seshadri, SP; Srinath, S1
Bryois, Ch; Sahli, Ch1
Jainer, AK; Sundararajan, V1
Andrade, C1
Gupta, SB; Laghate, VD1
Winter, AS; Witschy, JK1
Canonico, PL; Colella, L; Dellarole, A; Ferri, S; Ghi, P; Orsetti, M1
Suryavanshi, P; Tadke, RR1
Donnelly, CA; Lamberton, PH; Torrey, EF; Webster, JP1
Canonico, PL; Colella, L; Dellarole, A; Ghi, P; Orsetti, M1
Cipriani, A; Geddes, JR; Rendell, JM1
Brecher, M; Nasrallah, HA; Paulsson, B1
Roberts-Thomson, KC; Teo, KS; Young, GD1
Brahm, NC; Carnahan, RM; Gutierres, SL1
Joo, YH; Kim, B; Kim, SJ; Son, JI1
Brodaty, H; Cumming, R; Forrester, L; Grayson, D; Hollis, J; Touyz, S2
Lorenz, RA; Weinstein, B1
Berk, M; Dodd, S; Lubman, DI; Ng, F; Tohen, M; Vieta, E; Wang, WV1
Donnelly, CA; Lamberton, PH; Webster, JP1
Costa, E; Dong, E; Grayson, DR; Guidotti, A; Nelson, M1
Kalra, B; Mendhekar, DN; Sekhar, S; Tekur, U1
Munhoz, RP; Teive, HA; Werneck, LC1
Avissar, S; Golan, M; Schreiber, G1
Di Cosimo, D; Girardi, N; Kotzalidis, GD; Lazanio, S; Manfredi, G; Savoja, V; Talamo, A; Tatarelli, R; Vento, A1
Rushlow, WJ; Sutton, LP1
Babin, SL; Larrison, AL; Patel, SS; Sereno, AB; Wassef, AA; Xing, Y1
Blow, FC; Chiang, C; Cunningham, F; Kales, HC; Kim, HM; Schneider, LS; Seyfried, LS; Valenstein, M; Zivin, K1
Hsu, MC; Kuo, CC; Ouyang, WC; Yeh, IN1
Alfarano, E; Carabellese, F; Catanesi, R; La Tegola, D1
Carroll, BT; Crosby, D; Peterson, J1
Uys, H1
Blazina, AR; Lara, DR; Vianna, MR1
Brown, R; Geddes, J; Taylor, MJ1
Csernansky, JG; Dong, H; Fang, D; Gallardo, C; Gerst, N; Keegan, J; Matsumoto, M; Montalvo-Ortiz, JL; Tetsuka, K; Tucker, C1
Asadollahi, S; Azadbakht, A; Hatamabadi, H; Heidari, K; Mirmohseni, L; Vafaee, R; Yunesian, S1
Boersma, NA; Heidema, J; Kuijpers, T; Schippers, H1
Barchukov, VG; Kundashev, UK; Morozov, IS; Salenko, YA; Zurdinov, AZ1
Csernansky, JG; Dong, H; Fang, D; Fisher, DW; Montalvo-Ortiz, JL; Rodríguez, G1
Ago, Y; Hara, Y; Hasebe, S; Hashimoto, H; Kawase, H; Matsuda, T; Nakazawa, T; Takuma, K; Tanabe, W; Taruta, A; Tsukada, S1
Amata, E; Dichiara, M; Floresta, G; Marrazzo, A; Parenti, C; Pittalà, V; Prezzavento, O; Rescifina, A1
Belahsen, MF; Bouchal, S; Ouali, O1
Chen, RYY; Reznik, R; Stanford, P1
Direk, M; Epcacan, S; Epcacan, Z; Okuyaz, C; Yildirim, DD1
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K1
Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J1
Doello, K; Mesas, C; Ortiz, R; Perazzoli, G; Quiñonero, F; Rama, AR; Vélez, C1
Ahmed, SH; Irfan, M; Nashwan, AJ; Niaz, F; Shaikh, TG; Tariq, S; Ullah, I; Waseem, S1

Reviews

15 review(s) available for haloperidol and valproic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Problems of neurological drug therapy in pregnancy].
    La Clinica terapeutica, 1989, Apr-30, Volume: 129, Issue:2

    Topics: Abnormalities, Drug-Induced; Anticonvulsants; Antiparkinson Agents; Carbamazepine; Chelating Agents; Female; Fetus; Haloperidol; Humans; Nervous System Diseases; Phenobarbital; Phenytoin; Pregnancy; Pregnancy Complications; Trimethadione; Valproic Acid

1989
Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:9

    Topics: Adult; Autoimmune Diseases; Chorea; Comorbidity; Haloperidol; Humans; Mental Disorders; Obsessive-Compulsive Disorder; Rheumatic Fever; Schizophrenia; Tic Disorders; Tourette Syndrome; Valproic Acid

1996
Neuroleptic malignant syndrome and severe thrombocytopenia: case report and literature review.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2000, Volume: 12, Issue:1

    Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia; Thrombocytopenia; Valproic Acid

2000
Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants.
    Southern medical journal, 2001, Volume: 94, Issue:3

    Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Antimanic Agents; Benzodiazepines; Breast Feeding; Carbamazepine; Cyclohexanecarboxylic Acids; Female; Fetus; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Infant, Newborn; Lithium; Mood Disorders; Olanzapine; Pirenzepine; Placenta; Pregnancy; Risk Factors; Valproic Acid

2001
[Organic solvent-related mental disorders].
    Ryoikibetsu shokogun shirizu, 2003, Issue:40

    Topics: Administration, Inhalation; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Haloperidol; Humans; International Classification of Diseases; Mental Recall; Psychotherapy; Self-Help Groups; Sensation; Social Support; Solvents; Substance-Related Disorders; Valproic Acid

2003
[Psychotropics and weight gain].
    Praxis, 2004, Aug-25, Volume: 93, Issue:35

    Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain

2004
Haloperidol alone or in combination for acute mania.
    The Cochrane database of systematic reviews, 2006, Jul-19, Issue:3

    Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid

2006
Quetiapine for acute mania in bipolar disorder.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, May-15, Volume: 64, Issue:10

    Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Haloperidol; Humans; Lithium Compounds; Quetiapine Fumarate; Valproic Acid

2007
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
    Journal of affective disorders, 2008, Volume: 110, Issue:1-2

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Double-Blind Method; Female; Haloperidol; Humans; Least-Squares Analysis; Male; Meta-Analysis as Topic; Olanzapine; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Smoking; Survival Analysis; Treatment Outcome; Valproic Acid

2008
Aripiprazole alone or in combination for acute mania.
    The Cochrane database of systematic reviews, 2013, Dec-17, Issue:12

    Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Lithium Compounds; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Valproic Acid

2013
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents.
    Future medicinal chemistry, 2017, Volume: 9, Issue:15

    Topics: Antineoplastic Agents; Cell Survival; Haloperidol; Histone Deacetylase Inhibitors; Humans; Phenylbutyrates; Prodrugs; Receptors, sigma; Signal Transduction; Valproic Acid

2017
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
    Molecular psychiatry, 2022, Volume: 27, Issue:2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid

2022
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
    Psychopharmacology, 2022, Volume: 239, Issue:10

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid

2022
Managing and treating Sydenham chorea: A systematic review.
    Brain and behavior, 2023, Volume: 13, Issue:6

    Topics: Anticonvulsants; Chorea; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Valproic Acid

2023

Trials

11 trial(s) available for haloperidol and valproic acid

ArticleYear
A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:4

    Topics: Acute Disease; Administration, Oral; Adult; Basal Ganglia Diseases; Bipolar Disorder; Haloperidol; Hospitalization; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Single-Blind Method; Treatment Outcome; Valproic Acid

1996
Combined treatment of schizophrenic psychoses with haloperidol and valproate.
    Pharmacopsychiatry, 1998, Volume: 31, Issue:4

    Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Biperiden; Brief Psychiatric Rating Scale; Chlorprothixene; Double-Blind Method; Drug Therapy, Combination; Electroencephalography; Haloperidol; Humans; Leukopenia; Schizophrenia; Valproic Acid

1998
Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:4

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Metabolic Clearance Rate; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Valproic Acid

1999
Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2

    Topics: Acute Disease; Administration, Oral; Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Perazine; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid

2000
Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:3

    Topics: Acute Disease; Adult; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; GABA Agonists; Haloperidol; Humans; Male; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Valproic Acid

2000
Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: clinical and economic implications.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:1

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Drug Therapy, Combination; Female; Haloperidol; Hospitalization; Humans; Male; Schizophrenia; Treatment Outcome; Valproic Acid

2001
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    The American journal of psychiatry, 2002, Volume: 159, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid

2002
A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
    Bipolar disorders, 2004, Volume: 6, Issue:5

    Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Imipramine; Lithium Carbonate; Male; Phenotype; Prospective Studies; Recovery of Function; Risperidone; Secondary Prevention; Severity of Illness Index; Valproic Acid

2004
Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
    Journal of clinical pharmacology, 2010, Volume: 50, Issue:6

    Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Injections, Intravenous; Lorazepam; Male; Middle Aged; Severity of Illness Index; Valproic Acid

2010
Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    International journal of psychiatry in clinical practice, 2012, Volume: 16, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Body Weight; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Hospitals, Psychiatric; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid; Young Adult

2012
Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial.
    International clinical psychopharmacology, 2015, Volume: 30, Issue:3

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Psychomotor Agitation; Valproic Acid

2015

Other Studies

91 other study(ies) available for haloperidol and valproic acid

ArticleYear
Functional group contributions to drug-receptor interactions.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:12

    Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship

1984
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:3

    Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization

2008
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
    Journal of medicinal chemistry, 2012, Jan-12, Volume: 55, Issue:1

    Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells.
    Journal of medicinal chemistry, 2016, 11-10, Volume: 59, Issue:21

    Topics: Angiogenesis Inhibitors; Cell Survival; Dose-Response Relationship, Drug; Endothelial Cells; Haloperidol; Humans; Microvessels; Molecular Structure; Neovascularization, Physiologic; Retina; Structure-Activity Relationship; Valproic Acid

2016
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2

    Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship

2017
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
    Nature, 2020, Volume: 583, Issue:7816

    Topics: Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Cloning, Molecular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Mass Spectrometry; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; Protein Binding; Protein Biosynthesis; Protein Domains; Protein Interaction Mapping; Protein Interaction Maps; Receptors, sigma; SARS-CoV-2; SKP Cullin F-Box Protein Ligases; Vero Cells; Viral Proteins

2020
Haloperidol Metabolite II Valproate Ester (
    Journal of medicinal chemistry, 2021, 09-23, Volume: 64, Issue:18

    Topics: Angiogenesis Inhibitors; Butyrophenones; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Melanoma; Pentanoic Acids; Piperidines; Prodrugs; Stereoisomerism; Uveal Neoplasms; Valerates

2021
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Biochemical aspects of Huntington's chorea.
    Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:6

    Topics: Adult; Age Factors; Blood Platelets; Brain Damage, Chronic; Dopamine; Dopamine beta-Hydroxylase; Female; Haloperidol; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Hyperkinesis; Intelligence; Male; Middle Aged; Motor Skills; Time Factors; Valproic Acid

1977
Pharmacology of Huntington's chorea. Personal experience.
    European neurology, 1977, Volume: 16, Issue:1-6

    Topics: Acetates; Adult; Aminobutyrates; Blood Cell Count; Bromocriptine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Physostigmine; Receptors, Dopamine; Valerates; Valproic Acid

1977
The treatment of the choreas and athetotic dystonias.
    Journal of the Royal College of Physicians of London, 1979, Volume: 13, Issue:1

    Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement Disorders; Phenelzine; Phenothiazines; Pimozide; Tetrabenazine; Valproic Acid

1979
Alopecia and mood stabilizers: two case reports.
    European archives of psychiatry and clinical neuroscience, 1992, Volume: 242, Issue:2-3

    Topics: Adult; Alopecia; Carbamazepine; Clorazepate Dipotassium; Depressive Disorder; Female; Fluvoxamine; Haloperidol; Hospitalization; Humans; Lithium Carbonate; Methotrimeprazine; Middle Aged; Schizophrenia; Valproic Acid

1992
Importance of treatment follow-up.
    Biological psychiatry, 1990, Sep-15, Volume: 28, Issue:6

    Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Haloperidol; Humans; Neurocognitive Disorders; Valproic Acid

1990
Clinical assessment and pharmacotherapy of the alcohol withdrawal syndrome.
    Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism, 1986, Volume: 4

    Topics: Adrenergic beta-Antagonists; Alcohol Drinking; Alcoholism; Anti-Anxiety Agents; Benzodiazepines; Chlormethiazole; Combined Modality Therapy; Diagnosis, Differential; Drug Administration Schedule; Ethanol; Haloperidol; Humans; Neuropsychological Tests; Substance Withdrawal Syndrome; Valproic Acid

1986
Forced normalization. Acute psychosis after seizure control in seven patients.
    Archives of neurology, 1987, Volume: 44, Issue:3

    Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Haloperidol; Humans; Male; Psychotic Disorders; Succinimides; Valproic Acid

1987
Efficacy of valproic acid in the treatment of Sydenham's chorea.
    Journal of child neurology, 1988, Volume: 3, Issue:2

    Topics: Adolescent; Chorea; Haloperidol; Humans; Male; Valproic Acid

1988
Lithium-induced downbeat nystagmus.
    Archives of neurology, 1988, Volume: 45, Issue:9

    Topics: Adult; Bipolar Disorder; Electrooculography; Female; Haloperidol; Humans; Lithium; Middle Aged; Nystagmus, Pathologic; Valproic Acid

1988
Bromocriptine-related psychosis and treatment.
    Biological psychiatry, 1985, Volume: 20, Issue:3

    Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Pituitary Neoplasms; Prolactin; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Valproic Acid

1985
The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients.
    Journal of clinical psychopharmacology, 1984, Volume: 4, Issue:5

    Topics: Adult; Antipsychotic Agents; Chlorpromazine; Drug Interactions; Electroencephalography; Female; Half-Life; Haloperidol; Humans; Kinetics; Male; Middle Aged; Schizophrenia; Valproic Acid

1984
Therapeutic aspects of kinesiogenic paroxysmal choreoathetosis and familial paroxysmal choreoathetosis of the Mount and Reback type.
    Journal of neurology, 1983, Volume: 230, Issue:3

    Topics: Adolescent; Adult; Aged; Alcohol Drinking; Athetosis; Carbamazepine; Child; Chorea; Female; Haloperidol; Humans; Male; Middle Aged; Motor Activity; Pedigree; Phenytoin; Primidone; Valproic Acid

1983
[Treatment of several psychotic states with the combination of valproic acid with diazepam].
    Annales medico-psychologiques, 1984, Volume: 142, Issue:9

    Topics: Acute Disease; Adult; Delusions; Diazepam; Drug Therapy, Combination; Female; Hallucinations; Haloperidol; Humans; Male; Middle Aged; Schizophrenia, Paranoid; Valproic Acid

1984
Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.
    Advances in biochemical psychopharmacology, 1980, Volume: 24

    Topics: Adult; Baclofen; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia; Valproic Acid

1980
Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Acta physiologica et pharmacologica Bulgarica, 1982, Volume: 8, Issue:3

    Topics: Aminooxyacetic Acid; Animals; Apomorphine; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Humans; Levodopa; Male; Picrotoxin; Rats; Stereotyped Behavior; Valproic Acid

1982
Effects of haloperidol, lithium, and valproate on phosphoinositide turnover in rat brain.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 46, Issue:2

    Topics: Animals; Brain Chemistry; Carbachol; Corpus Striatum; Drug Interactions; Haloperidol; Lithium; Male; Norepinephrine; Phosphatidylinositols; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Valproic Acid

1993
Acute manic episodes in pregnancy.
    The American journal of psychiatry, 1996, Volume: 153, Issue:2

    Topics: Adult; Bipolar Disorder; Chlorpromazine; Comorbidity; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Haloperidol; Humans; Lorazepam; Pregnancy; Pregnancy Complications; Valproic Acid

1996
Hyperkinesias in a prepubertal boy with autistic disorder treated with haloperidol and valproic acid.
    Psychological reports, 1997, Volume: 80, Issue:1

    Topics: Anti-Dyskinesia Agents; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Bangladesh; Child; Drug Therapy, Combination; Epilepsy, Generalized; Haloperidol; Humans; Intellectual Disability; Male; Valproic Acid

1997
Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
    Pharmacopsychiatry, 1998, Volume: 31, Issue:5

    Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Delirium; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Lithium Carbonate; Middle Aged; Valproic Acid

1998
The use of haloperidol and valproate in children with Sydenham chorea.
    Indian pediatrics, 1998, Volume: 35, Issue:12

    Topics: Adolescent; Alanine Transaminase; Anti-Dyskinesia Agents; Anticonvulsants; Aspartate Aminotransferases; Child; Child, Preschool; Chorea; Female; Follow-Up Studies; Haloperidol; Humans; Liver; Male; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Valproic Acid

1998
Mania onset while using dehydroepiandrosterone.
    The American journal of psychiatry, 1999, Volume: 156, Issue:6

    Topics: Acute Disease; Bipolar Disorder; Dehydroepiandrosterone; Drug Therapy, Combination; Haloperidol; Humans; Male; Middle Aged; Valproic Acid

1999
[Manic syndrome: diagnostic trends and principles of treatment].
    La Revue du praticien, 1998, Apr-01, Volume: 48, Issue:7

    Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Diagnosis, Differential; Haloperidol; Hospitalization; Humans; Iatrogenic Disease; Lithium; Neurocognitive Disorders; Schizophrenia; Syndrome; Time Factors; Valproic Acid

1998
Cerebellar ataxia with intravenous valproate and haloperidol.
    The Australian and New Zealand journal of psychiatry, 2002, Volume: 36, Issue:2

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cerebellar Ataxia; Haloperidol; Humans; Injections, Intravenous; Male; Valproic Acid

2002
Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2002, Volume: 9, Issue:2

    Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Antioxidants; Disease Models, Animal; Dyskinesia, Drug-Induced; Ergosterol; Glycosides; Haloperidol; Male; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Sitosterols; Solanaceae; Valproic Acid; Vitamin E; Withanolides

2002
Management of rheumatic chorea: an observational study.
    Arquivos de neuro-psiquiatria, 2002, Volume: 60, Issue:2-A

    Topics: Anti-Dyskinesia Agents; Child; Chorea; Cross-Sectional Studies; Diazepam; Female; Haloperidol; Humans; Male; Sulpiride; Valproic Acid

2002
Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients.
    Arquivos de neuro-psiquiatria, 2002, Volume: 60, Issue:2-B

    Topics: Adolescent; Anti-Dyskinesia Agents; Antimanic Agents; Carbamazepine; Child; Chorea; Female; Follow-Up Studies; Haloperidol; Humans; Male; Prospective Studies; Treatment Outcome; Valproic Acid

2002
[Landau-Kleffner and autistic regression: the importance of differential diagnosis].
    Arquivos de neuro-psiquiatria, 2002, Volume: 60, Issue:3-B

    Topics: Anticonvulsants; Autistic Disorder; Child, Preschool; Diagnosis, Differential; Electroencephalography; Haloperidol; Humans; Landau-Kleffner Syndrome; Male; Promethazine; Valproic Acid

2002
Effect of Emblica officinalis tannoids on a rat model of tardive dyskinesia.
    Indian journal of experimental biology, 2000, Volume: 38, Issue:9

    Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Antioxidants; Brain; Disease Models, Animal; Dyskinesia, Drug-Induced; Euphorbiaceae; GABA Modulators; Haloperidol; Male; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Tannins; Valproic Acid; Vitamin E

2000
Lack of effect of mood stabilizers or neuroleptics on GSK-3 protein levels and GSK-3 activity.
    The international journal of neuropsychopharmacology, 2003, Volume: 6, Issue:2

    Topics: Affect; Animals; Antimanic Agents; Antipsychotic Agents; Blotting, Western; Chlorpromazine; Clozapine; Frontal Lobe; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Haloperidol; Lithium; Rats; Rats, Sprague-Dawley; Valproic Acid

2003
[Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Dopamine Antagonists; Drug Therapy, Combination; Haloperidol; Humans; Isotopes; Lithium; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Time Factors; Valproic Acid

2003
Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.
    Journal of child and adolescent psychopharmacology, 2003,Winter, Volume: 13, Issue:4

    Topics: Adolescent; Aggression; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Clonazepam; Diagnosis, Differential; Education; Family; GABA Modulators; Haloperidol; Hospitalization; Humans; Irritable Mood; Lithium; Lorazepam; Male; Piperazines; Psychiatric Status Rating Scales; Sexual Behavior; Thiazoles; Valproic Acid

2003
Olanzapine: new indication. New indication in acute mania: just another neuroleptic.
    Prescrire international, 2004, Volume: 13, Issue:70

    Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; France; Haloperidol; Humans; Valproic Acid

2004
Valproic acid induces manifestations of simultaneous dopamine enhancement and reduction in schizophrenia.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:6

    Topics: Adult; Benztropine; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Female; GABA Agents; gamma-Aminobutyric Acid; Haloperidol; Humans; Muscarinic Antagonists; Schizophrenia; Time Factors; Valproic Acid

2004
Olanzapine for injection: new formulation. No advantage in agitated patients.
    Prescrire international, 2004, Volume: 13, Issue:71

    Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; France; Haloperidol; Humans; Injections, Intramuscular; Valproic Acid

2004
A mood stabilizer with risperidone or haloperidol for mania.
    The American journal of psychiatry, 2004, Volume: 161, Issue:11

    Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Ethics, Research; Haloperidol; Humans; Lithium; Patient Selection; Placebos; Randomized Controlled Trials as Topic; Research Design; Risperidone; Valproic Acid

2004
A mood stabilizer with risperidone or haloperidol for mania.
    The American journal of psychiatry, 2004, Volume: 161, Issue:11

    Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Haloperidol; Humans; Randomized Controlled Trials as Topic; Research Design; Risperidone; Treatment Outcome; Valproic Acid

2004
Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol.
    The Journal of the Association of Physicians of India, 2004, Volume: 52

    Topics: Acute Disease; Adult; Antimanic Agents; Bipolar Disorder; Chlorpromazine; Diabetic Ketoacidosis; Diagnosis, Differential; Haloperidol; Humans; Male; Pancreatitis; Valproic Acid

2004
Improvement in tardive dyskinesia with aripiprazole use.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Long-Term Care; Middle Aged; Piperazines; Quinolones; Risperidone; Valproic Acid

2005
Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats.
    The international journal of neuropsychopharmacology, 2006, Volume: 9, Issue:4

    Topics: Amitriptyline; Animals; Antidepressive Agents; Benzodiazepines; Eating; Haloperidol; Male; Olanzapine; Rats; Rats, Wistar; Self Administration; Sucrose; Valproic Acid

2006
Use of intravenous valproate in a patient with neuroleptic malignant syndrome.
    The Journal of neuropsychiatry and clinical neurosciences, 2006,Winter, Volume: 18, Issue:1

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Creatine Kinase; Diagnosis, Differential; Female; Haloperidol; Humans; Infusions, Intravenous; Injections, Intramuscular; Neuroleptic Malignant Syndrome; Valproic Acid

2006
Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour.
    Proceedings. Biological sciences, 2006, Apr-22, Volume: 273, Issue:1589

    Topics: Animals; Antimanic Agents; Antiprotozoal Agents; Antipsychotic Agents; Behavior, Animal; Cats; Dapsone; Haloperidol; Humans; Mood Disorders; Pyrimethamine; Rabbits; Rats; Toxoplasma; Toxoplasmosis, Animal; Valproic Acid

2006
Modification of spatial recognition memory and object discrimination after chronic administration of haloperidol, amitriptyline, sodium valproate or olanzapine in normal and anhedonic rats.
    The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:3

    Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Food Preferences; Haloperidol; Male; Maze Learning; Memory; Olanzapine; Rats; Rats, Wistar; Recognition, Psychology; Space Perception; Stress, Psychological; Taste; Valproic Acid

2007
Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Bipolar disorders, 2006, Volume: 8, Issue:5 Pt 1

    Topics: Adult; Akathisia, Drug-Induced; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium Compounds; Male; Middle Aged; Multicenter Studies as Topic; Neurologic Examination; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Valproic Acid

2006
Drug-induced Brugada syndrome with ST-T wave alternans and long QT.
    Internal medicine journal, 2007, Volume: 37, Issue:3

    Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Arrhythmias, Cardiac; Bipolar Disorder; Brugada Syndrome; Electrocardiography; Fatal Outcome; Haloperidol; Humans; Lithium Compounds; Long QT Syndrome; Male; Valproic Acid

2007
Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients.
    Journal of affective disorders, 2008, Volume: 105, Issue:1-3

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Hospitalization; Humans; Lithium Carbonate; Male; Obesity; Olanzapine; Risperidone; Smoking; Valproic Acid

2008
Risk of death associated with antipsychotic drug dispensing in residential aged care facilities.
    The Australian and New Zealand journal of psychiatry, 2007, Volume: 41, Issue:9

    Topics: Aged; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Carbamazepine; Cause of Death; Chlorpromazine; Comorbidity; Cross-Sectional Studies; Death, Sudden; Female; Haloperidol; Homes for the Aged; Humans; Male; Nursing Homes; Olanzapine; Risk; Valproic Acid; Veterans

2007
Resolution of haloperidol-induced hyperprolactinemia with aripiprazole.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Piperazines; Prolactin; Quinolones; Valproic Acid

2007
Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2007, Volume: 15, Issue:11

    Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Carbamazepine; Cause of Death; Chlorpromazine; Cohort Studies; Dementia; Female; Haloperidol; Humans; Male; Mortality; Olanzapine; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors; Survival Rate; Valproic Acid; Veterans; Widowhood

2007
Specificity of the Toxoplasma gondii-altered behaviour to definitive versus non-definitive host predation risk.
    Parasitology, 2008, Volume: 135, Issue:10

    Topics: Animals; Behavior, Animal; Cats; Dapsone; Haloperidol; Pyrimethamine; Rats; Species Specificity; Toxoplasma; Toxoplasmosis, Animal; Valproic Acid

2008
Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Sep-09, Volume: 105, Issue:36

    Topics: Acetylation; Animals; Benzodiazepines; Brain; Cell Adhesion Molecules, Neuronal; Clozapine; DNA Methylation; Extracellular Matrix Proteins; Glutamate Decarboxylase; Haloperidol; Histones; Lysine; Male; Mice; Nerve Tissue Proteins; Olanzapine; Promoter Regions, Genetic; Reelin Protein; Serine Endopeptidases; Sulpiride; Valproic Acid

2008
The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
    Clinical neurology and neurosurgery, 2010, Volume: 112, Issue:5

    Topics: Aged; Antipsychotic Agents; Cinnarizine; Cohort Studies; Diagnosis, Differential; Female; Flunarizine; Haloperidol; Humans; Male; Methotrimeprazine; Movement Disorders; Outpatient Clinics, Hospital; Parkinsonian Disorders; Psychotic Disorders; Risperidone; Severity of Illness Index; Time Factors; Valproic Acid

2010
Antidepressants elevate GDNF expression and release from C₆ glioma cells in a β-arrestin1-dependent, CREB interactive pathway.
    The international journal of neuropsychopharmacology, 2011, Volume: 14, Issue:10

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Arrestins; beta-Arrestins; Brain Neoplasms; Cell Line, Tumor; Citalopram; Cyclic AMP Response Element-Binding Protein; Desipramine; Dose-Response Relationship, Drug; Glial Cell Line-Derived Neurotrophic Factor; Glioblastoma; Haloperidol; Imipramine; Neurotransmitter Uptake Inhibitors; Phosphorylation; Rats; RNA Interference; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Transcription, Genetic; Transfection; Up-Regulation; Valproic Acid

2011
Folie à deux: double case-report of shared delusions with a fatal outcome.
    La Clinica terapeutica, 2011, Volume: 162, Issue:1

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Clozapine; Combined Modality Therapy; Epilepsy; Fatal Outcome; Female; Haloperidol; Humans; Nordazepam; Olanzapine; Patient Compliance; Psychotherapy; Psychotic Disorders; Schizophrenia, Paranoid; Shared Paranoid Disorder; Sibling Relations; Suicide; Valproic Acid

2011
The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling.
    Neuroscience, 2011, Dec-29, Volume: 199

    Topics: Animals; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; beta Catenin; Blotting, Western; Brain; Clozapine; Fluoxetine; Glycogen Synthase Kinase 3; Haloperidol; Imipramine; Immunoprecipitation; Lithium; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Valproic Acid

2011
Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia.
    Human psychopharmacology, 2011, Volume: 26, Issue:7

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Case-Control Studies; Cognition; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Saccades; Schizophrenia; Valproic Acid; Young Adult

2011
Risk of mortality among individual antipsychotics in patients with dementia.
    The American journal of psychiatry, 2012, Volume: 169, Issue:1

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Olanzapine; Propensity Score; Quetiapine Fumarate; Retrospective Studies; Risk; Risperidone; Time Factors; Valproic Acid

2012
Coexistence and independence between a mental disorder and female stalking.
    Journal of forensic sciences, 2013, Volume: 58, Issue:1

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Commitment of Mentally Ill; Dibenzothiazepines; Female; Forensic Psychiatry; Haloperidol; Humans; Quetiapine Fumarate; Stalking; Valproic Acid

2013
Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2013, Volume: 25, Issue:1

    Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Haloperidol; Humans; Influenza A Virus, H1N1 Subtype; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Pneumonia, Viral; Schizophrenia; Treatment Outcome; Valproic Acid; Withholding Treatment

2013
Prevalence and clinical presentation of HIV positive female psychiatric inpatients.
    African journal of psychiatry, 2013, Volume: 16, Issue:1

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Comorbidity; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Female; Haloperidol; HIV Seropositivity; Humans; Mental Disorders; Middle Aged; Mood Disorders; Patient Admission; Prospective Studies; Psychotic Disorders; Recurrence; South Africa; Substance-Related Disorders; Valproic Acid

2013
The spinning task: a new protocol to easily assess motor coordination and resistance in zebrafish.
    Zebrafish, 2013, Volume: 10, Issue:4

    Topics: Animal Experimentation; Animals; Body Size; Clonazepam; Ethanol; Female; Haloperidol; Locomotion; Male; Psychomotor Performance; Sex Factors; Swimming; Valproic Acid; Zebrafish

2013
HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:6

    Topics: Acetylation; Aging; Animals; Avoidance Learning; Benzamides; Conditioning, Psychological; Dopamine Antagonists; Genes, fos; Haloperidol; Histone Deacetylase Inhibitors; Histones; Male; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Prefrontal Cortex; Pyridines; Valproic Acid

2014
Successful treatment of Sydenham's chorea with intravenous immunoglobulin.
    BMJ case reports, 2016, Feb-01, Volume: 2016

    Topics: Anti-Bacterial Agents; Child; Chorea; Disease Progression; Female; Haloperidol; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Severity of Illness Index; Treatment Outcome; Valproic Acid

2016
[EFFECT OF MEDIATOR-TYPE DRUGS ON HUMAN PSYCHOPHYSIOLOGICAL STATUS DURING MODEL OPERATOR ACTIVITY].
    Eksperimental'naia i klinicheskaia farmakologiia, 2016, Volume: 79, Issue:2

    Topics: Adult; Anabasine; Attention; Belladonna Alkaloids; Benzodiazepines; Central Nervous System Stimulants; Dioxanes; Double-Blind Method; Haloperidol; Humans; Isoproterenol; Male; Propranolol; Psychophysiology; Sydnones; Task Performance and Analysis; Tranquilizing Agents; Valproic Acid; Yohimbine

2016
Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice.
    Psychopharmacology, 2017, Volume: 234, Issue:16

    Topics: Acetylation; Aging; Animals; Benzamides; Corpus Striatum; Dopamine Antagonists; Haloperidol; Histone Deacetylase Inhibitors; Histones; Male; Mice; Mice, Inbred C57BL; Motor Activity; Pyridines; Valproic Acid

2017
Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
    Psychopharmacology, 2017, Volume: 234, Issue:21

    Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Dendritic Spines; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Female; Haloperidol; Male; Mice; Mice, Inbred ICR; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Risperidone; Social Behavior; Valproic Acid

2017
[Exceptionally good response to sodium valproate in patients with recurrent Sydenham's chorea].
    The Pan African medical journal, 2017, Volume: 27

    Topics: Adolescent; Anticonvulsants; Chorea; Female; Follow-Up Studies; Haloperidol; Humans; Recurrence; Rheumatic Fever; Treatment Outcome; Valproic Acid

2017
Clozapine toxicity in a CYP2D6 poor metaboliser: Additive effects of haloperidol and valproate on clozapine metabolism.
    Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2018, Volume: 26, Issue:6

    Topics: Adult; Antipsychotic Agents; Clozapine; Cytochrome P-450 CYP2D6; Drug Synergism; Haloperidol; Humans; Male; Schizophrenia; Valproic Acid; Young Adult

2018
Efficacy of levetiracetam in the treatment of Sydenham chorea.
    Pediatrics international : official journal of the Japan Pediatric Society, 2020, Volume: 62, Issue:11

    Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Chorea; Female; Haloperidol; Humans; Levetiracetam; Male; Retrospective Studies; Valproic Acid

2020
Antitumor Effect of Traditional Drugs for Neurological Disorders: Preliminary Studies in Neural Tumor Cell Lines.
    Neurotoxicity research, 2022, Volume: 40, Issue:6

    Topics: Adult; Apoptosis; Biperiden; Brain Neoplasms; Cell Line, Tumor; Dextromethorphan; Fingolimod Hydrochloride; Glioblastoma; Haloperidol; Humans; Levetiracetam; Methotrimeprazine; Valproic Acid

2022